Public health expert with a medical and research background. Alasdair is an accomplished leader with decades of experience wrought by dedication to create positive impact.

Alasdair Godfrey joined Health Technology Analysts when it was part of Optum UHG as the APAC Regional Leader. After a management buy-out he is now co-owner and Managing Director with strategic oversight of the entire organisation and team.

Alasdair has previously held varied roles in the health technology and pharma industries, as well as medical market access positions at a large global healthcare consultancy. As clinical and health policy expert he has been an evaluator for the Australian Medical Services Advisory Committee (MSAC) managing several complex evaluations of medical devices, co-dependent technologies, diagnostic tests and clinical services. Alasdair has also led in the creation of several clinical practice guidelines.

Alasdair has participated in a range of consultative groups and expert committees with the Pharmaceutical Benefits Division (PBD), Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Technology Association of Australia (MTAA) regarding patient access, health policy and evidence-based decision making.

Alasdair has a medical and scientific background with degrees in Medicine and Genetics. Before moving to Australia in the early 2000’s he held clinical, research and academic positions in the UK (Cambridge and Glasgow) mainly focused in the therapeutic areas of oncology and autoimmune diseases. Alasdair has interests in health policy, genomic research and equitable access to the best healthcare.